Pharmaceuticals, Biotechnology and Life Sciences
Takeda has ensured the signature to buy USA-based drugmaker focused on producing cancer treatments, Ariad Pharmaceuticals for about $5.2 billion, or $24 per share in cash for stockholders.
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
In 2016, mega deals became ever more transformative.
German drug and crop chemical maker Bayer AG announced its $66 billion takeover of U.S. agrochemicals company Monsanto Co, while ChemChina signed a $43 billion acquisition of Swiss seeds group Syngenta AG, as consolidation in the sector intensified.
When her father’s lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.
Premaitha has announced the conditional acquisition of the entire issued share capital of Yourgene.
Japan said on Tuesday it will step up the pace and expand the scope of drug price reviews, one of the most aggressive measures it is taking to rein in ballooning healthcare costs for a rapidly ageing nation.
Bangladesh-based drugmaker Beximco has received approval for its Bristol-Myers Squibb’s (BMS) generic equivalent Glucophage XR tablets, Metformin from the US…
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug